Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sands

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Psychiatry|August 1, 1986
The use of hypnosis in establishing a holding environment to facilitate affect tolerance and integration in impulsive patientsS Sands
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
AAV-mediated liver-directed gene therapyMark S Sands
Pediatric Endocrinology Reviews : PER|October 28, 2014
Mucopolysaccharidosis type VII: A powerful experimental system and therapeutic challengeMark S Sands
Journal of Child Neurology|September 10, 2013
Considerations for the treatment of infantile neuronal ceroid lipofuscinosis (infantile Batten disease)Mark S Sands
Biochemical Society Transactions|September 19, 2014
Astrocytosis in infantile neuronal ceroid lipofuscinosis: friend or foe?Charles Shyng, Mark S Sands
Psychiatry|November 1, 1986
The concept of noiseS Sands, J J Ratey
Pediatric Neurology|September 22, 2014
Experimental therapies in the murine model of globoid cell leukodystrophyYedda Li, Mark S Sands
Journal of Neuroscience Research|September 18, 2016
Treatment for Krabbe's disease: Finding the combinationChristina R Mikulka, Mark S Sands
Nucleic Acids Research|June 11, 1992
Binding of TFIIIA to derivatives of 5S RNA containing sequence substitutions or deletions defines a minimal TFIIIA binding siteD F Bogenhagen, M S Sands
Molecular and Cellular Biology|November 1, 1987
TFIIIA binds to different domains of 5S RNA and the Xenopus borealis 5S RNA geneM S Sands, D F Bogenhagen
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Psychiatry|August 1, 1986
The use of hypnosis in establishing a holding environment to facilitate affect tolerance and integration in impulsive patientsS Sands
Methods in Molecular Biology (Clifton, N.J.)|October 29, 2011
AAV-mediated liver-directed gene therapyMark S Sands
Pediatric Endocrinology Reviews : PER|October 28, 2014
Mucopolysaccharidosis type VII: A powerful experimental system and therapeutic challengeMark S Sands
Journal of Child Neurology|September 10, 2013
Considerations for the treatment of infantile neuronal ceroid lipofuscinosis (infantile Batten disease)Mark S Sands
Biochemical Society Transactions|September 19, 2014
Astrocytosis in infantile neuronal ceroid lipofuscinosis: friend or foe?Charles Shyng, Mark S Sands
Psychiatry|November 1, 1986
The concept of noiseS Sands, J J Ratey
Pediatric Neurology|September 22, 2014
Experimental therapies in the murine model of globoid cell leukodystrophyYedda Li, Mark S Sands
Journal of Neuroscience Research|September 18, 2016
Treatment for Krabbe's disease: Finding the combinationChristina R Mikulka, Mark S Sands
Nucleic Acids Research|June 11, 1992
Binding of TFIIIA to derivatives of 5S RNA containing sequence substitutions or deletions defines a minimal TFIIIA binding siteD F Bogenhagen, M S Sands
Molecular and Cellular Biology|November 1, 1987
TFIIIA binds to different domains of 5S RNA and the Xenopus borealis 5S RNA geneM S Sands, D F Bogenhagen
Pageof 20